Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Anesthesiology. 2012 Jul;117(1):22–37. doi: 10.1097/ALN.0b013e31825a2a4e

Table 2.

Subjective aversive and reinforcing effects in twins receiving saline placebo before alfentanil

Variables (VAS) Median effect (IQR) Incidence (%)
Saline Alfentanil Saline Alfentanil
Sedation 0 (0–15) 75 (60–87) 48 100
Dizziness - average 0 (0–0) 15 (0–40) 8 67
- maximum 0 (0–0) 30 (0–70) 8 68
Nausea - average 0 (0–0) 1 (0–32) 3 50
- maximum 0 (0–0) 8 (0–70) 3 50
Pruritus - average 0 (0–0) 20 (0–45) 15 71
- maximum 0 (0–0) 35 (0–65) 18 72
Liking - average 0 (0–0) 50 (0–75) 12 67
- maximum 0 (0–0) 75 (40–90) 12 80
Disliking - maximum 0 (0–0) 23 (0–70) 5 65

IQR = inter-quartile range, VAS = visual analogue scale